Company / Interest Expense per Share
Summit Therapeutics Inc. Interest Expense per Share History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.08
FY2023
5-year range
$0.00 / $0.08
FY2019-FY2023
Trend
+3059.2%
vs FY2022
Sector context
#27 of 43
Health Care
What the data says
Interest Expense per Share changed +3059% YoY in FY2023, a notable deviation from the 5-year average annual change of +618%.
Based on SEC 10-K filings.
0.08 in FY2023 with a 5-year CAGR of +16.7%.
Increased from $0.00 to $0.08 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +173.9%
- 5-Year CAGR
- +16.7%
- 10-Year CAGR
- -
Sector benchmark
#17 of 43 in Health CareTop 37% of 43This company $0.08 Sector average $18.61
▼
-99.6% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 3059.2% year-over-year.
- Ranks #27 out of 43 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.08 | +3059.2% |
| FY2022 | $0.00 | +242.9% |
| FY2021 | $0.00 | -81.0% |
| FY2020 | $0.00 | -57.2% |
| FY2019 | $0.01 | -75.4% |
| FY2018 | $0.04 | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026